Cargando…

The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability

A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of...

Descripción completa

Detalles Bibliográficos
Autores principales: Althabhawi, Nabeel M., Zainol, Zinatul Ashiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773692/
https://www.ncbi.nlm.nih.gov/pubmed/35053272
http://dx.doi.org/10.3390/biom12010124
_version_ 1784636156466429952
author Althabhawi, Nabeel M.
Zainol, Zinatul Ashiqin
author_facet Althabhawi, Nabeel M.
Zainol, Zinatul Ashiqin
author_sort Althabhawi, Nabeel M.
collection PubMed
description A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies.
format Online
Article
Text
id pubmed-8773692
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87736922022-01-21 The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability Althabhawi, Nabeel M. Zainol, Zinatul Ashiqin Biomolecules Review A combination of 3D printing techniques and synthetic biology, 3D bioprinting is a promising field. It is expected that 3D bioprinting technologies will have applications across an array of fields, spanning biotechnology, medical surgery and the pharmaceutical industry. Nonetheless, the progress of these technologies could be hindered, unless there is adequate and effective protection for related applications. In this article, the authors examine the patent eligibility of 3D bioprinting technologies. This issue raises concern given that existing patent systems are generally averse to nature-derived inventions and many of them exclude products of nature or discoveries from patentability. This qualitative study analyses the current patent systems in key jurisdictions, particularly, the U.S. and the EU, and their applicability, as well as effectiveness, in the context of 3D bioprinting. The study argues that the main reason for the apathy of existing patent systems towards bio-inventions is that they were designed to deal with mechanical inventions. It suggests an innovation framework that encompasses both mechanical and biological inventions to cater adequately to emerging technologies. MDPI 2022-01-12 /pmc/articles/PMC8773692/ /pubmed/35053272 http://dx.doi.org/10.3390/biom12010124 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Althabhawi, Nabeel M.
Zainol, Zinatul Ashiqin
The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title_full The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title_fullStr The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title_full_unstemmed The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title_short The Patent Eligibility of 3D Bioprinting: Towards a New Version of Living Inventions’ Patentability
title_sort patent eligibility of 3d bioprinting: towards a new version of living inventions’ patentability
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773692/
https://www.ncbi.nlm.nih.gov/pubmed/35053272
http://dx.doi.org/10.3390/biom12010124
work_keys_str_mv AT althabhawinabeelm thepatenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability
AT zainolzinatulashiqin thepatenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability
AT althabhawinabeelm patenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability
AT zainolzinatulashiqin patenteligibilityof3dbioprintingtowardsanewversionoflivinginventionspatentability